IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Aurobindo to acquire Hyacinths Pharma as part of APIs push

7:19 AM MDT | September 13, 2013 | Natasha Alperowicz

Aurobindo Pharma (Hyderabad, India) says it will acquire, from existing private shareholders, Hyacinths Pharma (Andhra Pradesh, India), a company incorporated to manufacture active pharmaceutical ingredients (APIs). Hyacinths, located near Aurobindo’s operations, has a 53-acre site at Srikakulum, India—also near Aurobindo—and all the necessary approvals to begin production of APIs. The acquisition forms part of Aurobindo’s previously announced plan to raise sales of APIs to $700 million by fiscal 2016. In fiscal 2013, the...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa